cenicriviroc

Cenicriviroc (TAK-652) 是一种可口服的CCR2 CCR5拮抗剂，可抑制 HIV-1 和 HIV-2，具有抗炎、抗感染作用。

Cenicriviroc Mesylate is a dual CCR2 CCR5 antagonist, also inhibits both HIV-1 and HIV-2 with anti-inflammatory and antiinfective activity.

Cenicriviroc Sulfone is a derivative of Cenicriviroc which is an experimental drug candidate for the treatment of HIV infection. It is an inhibitor of CCR2 and CCR5 receptors allowing it to function as an entry inhibitor which prevents the virus from entering into a human cell.